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INTRODUCTION METHODS
RESULTS
CONCLUSIONS
• 17b-Estradiol up-regulates GDNF expression in substantia nigra cultures.
• L-DOPA and H2O2 augmented the effect of 17b-estradiol on GDNF expression, in vitro.
• 17b-Estradiol exerts a neuroprotective effect in vivo on selectively injured substantia nigra DA neurons. This effect may be 
mediated by an up-regulation of GDNF expression.
Parkinson’s disease (PD) is a movement disorder characterized by the progressive degeneration of 
dopaminergic (DA) neurons projecting to the striatum. Oxidative stress in the nigrostriatal pathway as well as 
deficient neurotrophic support could be factors triggering neurodegeneration in the substantia nigra. The 
incidence of PD is greater in men than women, suggesting that estrogens may play a protective role in the 
progression of this disease. The estradiol is considered a neuroprotective agent for nigral DA neurons and its 
action has been related to its capacity to reduce the oxidative stress or to regulate the expression of 
neurotrophic factors. One possible candidate for estradiol regulation is the glial cell line-derived neurotrophic 
factor (GDNF), a potent factor for the protection of DA neurons which is able to prevent or reverse the 
neurodegenerative process observed in PD.
This work aimed at studying the effect of 17b-estradiol on GDNF expression in postnatal substantia nigra cell 
cultures and the relevance of this effect to the neuroprotective action of this hormone. The ability of levodopa 
(L-DOPA, the main symptomatic treatment for PD) or H2O2 (a by-product of dopamine metabolism that 
increases oxidative stress) to modulate this effect was also evaluated.
Figure 3 – Effect of 17b-estradiol on the nigrostriatal pathway, in vivo. Adult male Wistar rats were implanted s.c. with a 7-day release 17b-estradiol or vehicle (control) microosmotic pump. Ten days 
later, the rats received a striatal unilateral injection of 6-OHDA or vehicle (control). The substantia nigra (A) and striatum (B) coronal slices were obtained five days after 6-OHDA injection and processed 
for tyrosine hydroxylase (TH) immunoreactivity (40x magnification). C) The substantia nigra coronal slices were obtained 15 days after 17b-estradio treatment and processed for GDNF immunoreactivity
(400x magnification). D) Number of TH-positive cells in the substantia nigra, in the ipsilateral side as compared to the contralateral side (considered 100%). Data shown are the mean ± S.E.M. of three 
independent experiments. Statistical analysis was performed using one-way ANOVA followed by Bonferroni’s test. ***P < 0.001 as compared to the contralateral side.
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Substantia nigra neuron-glia cocultures
Substantia nigra cells were isolated from P2-P3 Wistar rat pups. Neurons were plated onto a confluent monolayer of ventral midbrain astrocytes upon conditioning 
with neuronal culture medium for 1-2 days. Under these conditions about 7% of total neurons were dopaminergic exhibiting long and branched processes.
Western blot analysis of GDNF levels
The samples (30-40 µg protein) were separated by SDS-PAGE on a 12% acrylamide gel. After electrotransfer onto PVDF membranes and blocking with 5% milk, 
the membranes were incubated with the primary antibody to GDNF (rabbit, 1:1000; Santa Cruz) overnight at 4ºC, and incubated with a secondary goat anti-rabbit 
IgG antibody conjugated to alkaline phosphatase (Amersham Life Sciences, 1:20000) for 1 h at RT. Immunoreactive bands were detected using the ECF system 
(Amersham Life Sciences) and quantified with the Quantity One software (Bio-Rad).
In vivo experiments
Adult male Wistar rats were implanted s.c. with a 7-day release 17b-estradiol or vehicle (control) microosmotic pump. Ten days later, the rats were unilaterally 
injected in the striatum with the selective DA toxin 6-hidroxydopamine (6-OHDA) or vehicle (control). Five days later the animals were sacrificed and coronal brain 
slices were obtained. The midbrain and striatum slices were processed for tyrosine hydroxylase (TH) and GDNF immunoreactivity using a primary antibody to TH 
(mouse, 1:1000; Transduction Laboratories) and to GDNF (rabbit, 1:500; Santa Cruz), and the biotinylated secondary anti-mouse IgG antibody (1:100; Abcam) and 
anti-I rabbit (1:20; Sigma) (1h incubation at RT).
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Figure 1 – GDNF expression in substantia nigra cultures exposed to different concentrations of 17b-estradiol. The cells were 
incubated with 17b-estradiol (0.01, 0.1, 1, 10 and 100 nM) for 48h and cell extracts were prepared for Western blot analysis of 
GDNF levels.  Data shown are the mean ± S.E.M. of up to nine independent experiments performed in triplicate. Statistical analysis 
was performed using one-way ANOVA followed by Dunnett’s test. *P < 0.05 and **P < 0.01 as compared to control.
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Figure 2 – Modulation of the 17b-estradiol-induced GDNF up-regulation by H2O2 (A) and L-DOPA (B) in substantia nigra cultures. The cells were incubated with different concentrations of 17b-estradiol 
(1, 10 and 100 nM) for 48h, in the presence (+) and absence (-) of H2O2 50 uM or L-DOPA 200 uM (24 h incubation). GDNF expression was assessed by Western blot analysis of cell extracts.  Data 
shown are the mean ± S.E.M. of up to nine independent experiments performed in triplicate. Statistical analysis was performed using one-way ANOVA followed by Dunnett’s test. *P < 0.05, **P < 0.01 as 
compared to control. #P < 0.05 as compared to 17b-estradiol 10 nM.
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L-DOPA and H2O2 augmented the effect of 17b-estradiol on GDNF expression in substantia 
nigra cultures
17b-Estradiol completely prevented the DA cell loss induced by the striatal injection of 6-
OHDA
C)
